In order to investigate the potential roles of PDK4 expression in rituximab resistance, we used three DLBCL cell lines, U2932, OCI‐ly7, and OCI‐ly8, for in vitro assays, including qRT‐PCR, flow cytometry, and western blotting assays. The gene discussed is PDK4; the disease is diffuse large B-cell lymphoma.